MMP13 and osteoporosis: In a group of women with osteopenia, MMP-13 again negatively correlated with E2 levels, as well as with CTX levels [13] Interestingly, a 6-month therapeutic course with recombinant human parathormone among women with osteoporosis clearly reduced serum MMP-13 levels by almost 37%.